A-Rod received therapeutic use exemptions for testosterone for several seasons before Biogenesis hit

41 Comments

There’s a book coming out soon about the Biogenesis scandal. It’s called “Blood Sport: Alex Rodriguez, Biogenesis and the Quest to End Baseball’s Steroid Era” by Tim Elfrink of the Miami New Times and Gus Garcia-Roberts of Newsday. Sports Illustrated is running a very tasty excerpt from it today.

The subject: Alex Rodriguez, not surprisingly. And while part of it is sexy — apparently, the first words out of A-Rod’s mouth to Tony Bosch were “What were you giving Manny Ramiez?” — there’s a more significant and more interesting part of it all too. Specifically: about the many therapeutic use exemptions A-Rod received to legally take testosterone before he hooked up with Biogenesis.

Therapeutic Use Exemptions — or TUEs as they’re often called — allow players to take otherwise banned drugs if they demonstrate a medical need to do so. These days we hear about them most often in connection with stimulants like Adderall, which are used to treat attention deficit disorder. Of course, a far greater percentage of players in Major League Baseball have therapeutic use exemptions for ADD medicine than the population at large has ADD, and for this reasons many look at the TUEs given for them with suspicion. As a means of players to obtain performance enhancing drugs without having to worry about being suspended.

In the book excerpt we learn that A-Rod received multiple TUEs during his time with the Yankees. But they weren’t for ADD medication. They were for testosterone, which is a really damn rare exemption to get. But A-Rod got it:

Before the 2007 season, Rodriguez asked for permission to use testosterone, which has been banned by baseball since 2003. The IPA in ’07 was Bryan W. Smith, a High Point, N.C., physician. (Baseball did not yet have the advisory medical panel.) On Feb. 16, 2007, two days before Rodriguez reported to spring training, Smith granted the exemption, allowing Rodriguez to use testosterone all season.

A-Rod won the MVP that year and, at the end of the year, famously opted out of his Yankees deal and signed his ten-year contract extension. Even after securing what he had to know was his last professional contract, A-Rod continued to apply for and receive TUEs. In 2008 he received a TUE for Clomid, which is similar to the drug that Manny Ramirez got busted for when he was with the Dodgers. A-Rod took it with Major League Baseball’s approval, however.

I’d be pretty interested to learn more about those TUEs A-Rod got. Why he got them when, apparently, a lot of people didn’t. Whether MLB believes it had been too permissive with them back then and whether A-Rod’s decision to quit relying on those and, instead, go an illegal route with Tony Bosch, angered them in some way. I’d also be curious to know if there is a psychological dependency at work with testosterone and other such drugs and whether Major League Baseball approving A-Rod’s use of the stuff contributed to whatever it was that drove A-Rod to continue to take PEDs, long after he ceased to have much if anything to prove on a baseball diamond.

The Pirates are, not surprisingly, leaning against trading Andrew McCutchen

Getty Images
Leave a comment

Over the winter there was serious talk about the Pirates trading Andrew McCutchen to the Washington Nationals. His move to left field to allow Starling Marte to take over center further served to make McCutchen a less important part of the Pirates long term plans.

Then the season began, Marte got suspended for PEDs and, after a bumpy start, McCutchen caught fire. He hit .411/.505/.689 in June he has a .333/.444/.561 line in the month of July. For the year he’s now at .292/.384/.507 with 17 homers and 57 RBI. Even with Marte back on the roster, McCutchen is the Pirates’ center fielder. What’s more, the Pirates, after beginning the season slowly have righted the ship somewhat and are now only three games back in the NL Central.

All of which makes this, from Rob Biertempfel of the Pittsburgh Tribune-Review, unsurprising:

That option is a quite reasonable $14.5 million, so it seems sorta crazy that they wouldn’t pick it up. Of course if they remain coy enough about it for now perhaps someone will bowl them over with an offer. Letting McCutchen walk seems insane. Unloading him for a hefty haul would, well, still be kinda crazy given how popular McCutchen is with the fan base, but not truly insane.

The Brewers are talking to the Tigers about Ian Kinsler, Justin Wilson

Getty Images
2 Comments

The Brewers were rumored last week to have been “aggressive” in talks for Tigers reliever Justin Wilson. ESPN’s Jerry Crasnick reports, however, that the talks are a bit more wide-ranging than that.

Crasnick says that the two clubs are also discussing Tigers second baseman Ian Kinsler, potentially in a package deal with Wilson. Crasnick says that the Brewers “would love to have Kinsler,” but their main focus at the moment is pitching help. Of course, the Brewers current second baseman — Jonathan Villar — is hitting a meager .223/.285/.348 in 334 plate appearances.

Kinsler is having a down season for him — .237/.331/.400 — but he’s better than that and, of course, would represent an improvement. He’s under contract through the end of this year but he has a very affordable, $10 million club option for 2018. Wilson will be arbitration-eligible this offseason, so he’s still under team control as well. As such a Kinsler/Wilson package would likely cost the Brewers a high price, so you have to think they’d try to exhaust cheaper options before making such a deal.

The Brewers had been in first place in the NL Central since June 7, but the Cubs caught them yesterday. They’re in a virtual tie, with Chicago percentage points ahead. This should prove to be a very interesting week for the Brewers’ front office.